ARTICLE | Clinical News
HemoCue Albumin 201 regulatory update
June 23, 2008 7:00 AM UTC
FDA granted CLIA waiver to Quest Diagnostics’ HemoCue AB subsidiary for HemoCue Albumin 201 for monitoring microalbuminuria. The quantitative point-of-case test measures levels of albumin, which can s...